fungal infections
RealSeq Biosciences Raises $1.5M in Oversubscribed Seed Financing Round
The company will use the funding to validate its RiboMarker platform and further develop its laboratory-developed test for Valley Fever.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
Immy Wins $1.5M NIH Contract for Point-of-Care Talaromycosis Test
Talaromycosis is an infection caused by airborne inhalation of the fungus Talaromyces marneffei and is endemic in Southeast Asia.
Pathonostics Gets CE Mark for Next-Gen Test for Fungal Skin Infections
The multiplex PCR test can detect and distinguish more than 15 fungal pathogens that cause dermatophytosis.
BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark
The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.